The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
出版年份 2018 全文链接
标题
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
作者
关键词
-
出版物
Current Oncology Reports
Volume 20, Issue 11, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-24
DOI
10.1007/s11912-018-0732-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
- (2018) Mingjie Dong et al. Cell Death & Disease
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014
- (2017) Joanne F. Aitken et al. INTERNATIONAL JOURNAL OF CANCER
- An age-dependent interaction between sex and geographical UV index in melanoma risk
- (2017) Feng Liu-Smith et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure
- (2017) Feng Liu-Smith et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
- (2017) Reinhard Dummer et al. LANCET ONCOLOGY
- Malignant Melanoma in African–Americans
- (2017) Krishnaraj Mahendraraj et al. MEDICINE
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanocytic nevi and melanoma: unraveling a complex relationship
- (2017) W E Damsky et al. ONCOGENE
- Epigenetics of malignant melanoma
- (2017) Bruce Moran et al. SEMINARS IN CANCER BIOLOGY
- NRAS-mutant melanoma: current challenges and future prospect
- (2017) Eva Muñoz-Couselo et al. OncoTargets and Therapy
- Clinical Features Associated With Individuals at Higher Risk of Melanoma
- (2017) Caroline G. Watts et al. JAMA Dermatology
- Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype
- (2016) Leonardo S. Lino-Silva et al. ANNALS OF SURGICAL ONCOLOGY
- The role of mitogen-activated protein targeting in melanoma beyond BRAFV600
- (2016) Ryan J. Sullivan CURRENT OPINION IN ONCOLOGY
- Survival of patients with advanced metastatic melanoma: The impact of novel therapies
- (2016) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031
- (2016) David C. Whiteman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
- (2016) F Stephen Hodi et al. LANCET ONCOLOGY
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
- (2016) Ximena Bonilla et al. NATURE GENETICS
- Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas
- (2016) Holger A. Haenssle et al. JAMA Dermatology
- mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
- (2015) William Damsky et al. CANCER CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Cell cycle control as a promising target in melanoma
- (2015) Belinda Lee et al. CURRENT OPINION IN ONCOLOGY
- The melanocyte lineage in development and disease
- (2015) R. L. Mort et al. DEVELOPMENT
- More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
- (2015) David C. Whiteman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
- (2015) Michael Krauthammer et al. NATURE GENETICS
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas
- (2015) Jonathan J. Lee et al. Clinical Epigenetics
- Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
- (2014) Moriah H. Nissan et al. CANCER RESEARCH
- Understanding the Biology of Melanoma and Therapeutic Implications
- (2014) Ryan J. Sullivan et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis
- (2014) Sophia Colantonio et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis
- (2014) R.J.T. van der Leest et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- BRAF inhibitor activity in V600R metastatic melanoma – Response
- (2013) Oliver Klein et al. EUROPEAN JOURNAL OF CANCER
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- UV Radiation and the Skin
- (2013) John D'Orazio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
- (2013) Arjen Joosse et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry
- (2013) Alan C. Geller et al. JOURNAL OF CLINICAL ONCOLOGY
- MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
- (2013) Paolo A Ascierto et al. LANCET ONCOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Deciphering Signatures of Mutational Processes Operative in Human Cancer
- (2013) Ludmil B. Alexandrov et al. Cell Reports
- Legislation Restricting Access to Indoor Tanning Throughout the World
- (2012) Mary T. Pawlak et al. ARCHIVES OF DERMATOLOGY
- Melanoma incidence and mortality in Europe: new estimates, persistent disparities
- (2012) A.M. Forsea et al. BRITISH JOURNAL OF DERMATOLOGY
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- A potential role for nilotinib inKIT-mutated melanoma
- (2012) An Tran et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Melanoma in Immunosuppressed Patients
- (2012) Agnieszka W. Kubica et al. MAYO CLINIC PROCEEDINGS
- Melanoma genome sequencing reveals frequent PREX2 mutations
- (2012) Michael F. Berger et al. NATURE
- MAP kinase signaling and inhibition in melanoma
- (2012) R J Sullivan et al. ONCOGENE
- A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important
- (2012) Feng Liu et al. Pigment Cell & Melanoma Research
- BRAF L597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors
- (2012) Kimberly Brown Dahlman et al. Cancer Discovery
- Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006
- (2011) Peter Baade et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboringc-KitMutation or Amplification
- (2011) Jun Guo et al. JOURNAL OF CLINICAL ONCOLOGY
- The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin
- (2011) David C. Whiteman et al. Pigment Cell & Melanoma Research
- Melanoma Thickness Trends in the United States, 1988–2006
- (2009) Vincent D. Criscione et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search